800-551-0488

Lab results are too important to go anywhere else

Beaumont Laboratory

Program

7:00 a.m.

Registration and continental breakfast

8:00 a.m.

Opening Remarks

8:05 – 9:05 a.m.

KEYNOTE: Practicing Pathology in the Era of Molecular Classification and Precision Medicine
Liang Cheng, M.D., Indiana University School of Medicine, Indianapolis

9:05 – 9:50 a.m.

AMP Sponsored Session:
Disruptive or Revolutionary? The Role of New Technologies in Molecular Diagnostics

Gregory J. Tsongalis, Ph.D., HCLD, CC, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine, Lebanon, New Hampshire

9:50 – 10:15 a.m.

Break (in Exhibit Hall)

10:15 - 11:00 a.m.

Antibiotic Resistance Prediction by Genomic Sequence-Guided Proteomics
John P. Dekker, M.D., Ph.D., National Institute of Health, Bethesda, Maryland

11:00 - 11:45 a.m.

Corporate Workshop*

12:00 - 1:00 p.m.

Lunch (in Exhibit Hall)

1:00 - 1:45 p.m.

Corporate Workshop*

2:00 - 2:45 p.m.

Elucidating Telomerase Function in Cancer Biology Using Genetically Defined Stem Cell Models
Dirk Hockemeyer, Ph.D., University of California, Berkeley, California

2:45 - 3:30 p.m.

Sequencing Comes to Rescue When All Else Fails
Niaz Banaei, M.D., Stanford University, Palo Alto, California

3:30 - 4:00 p.m.

Break (in Exhibit Hall)

4:00 - 4:45 p.m.

Next Generation Antibiotic Resistance Detection
David M. Engelthaler, Ph.D.,Translational Genomics Research Institute (TGen), Flagstaff, Arizona

4:45 - 6:00 p.m.

Wine and Cheese Reception
Corporate Exhibits open until 6:00 p.m.

*The corporate workshops are not endorsed by Beaumont Health and are not part of the CME activity. 

Wednesday Program Moderators:
Bobby Boyanton, Jr., M.D., Medical Director, Microbiology, and Medical Director, Molecular Pathology, Beaumont Health, Royal Oak
Barbara Robinson-Dunn, Ph.D., D(ABMM), Technical Director, Microbiology, Beaumont Health, Royal Oak
Mark Micale, Ph.D., Director, Clinical Cytogenetics, Beaumont Health, Royal Oak 

“Go Green”
In accordance to be environmentally responsible, we are taking a “Go Green” approach to conference materials this year. No printed presentation materials will be provided. Handouts approved by speakers may be available for download one week prior to symposium. 


7:00 a.m.

Registration and continental breakfast

8:00 a.m. – 8:45 a.m.

AMP Sponsored Session: Molecular Biomarkers in Colorectal Cancer
Antonia Sepulveda, M.D., Ph.D., Columbia University Medical Center, New York City, New York

8:45 – 9:30 a.m.

The Aging Genome, Clonal Mosaicism, and Cancer Risk
Mitchell Machiela, Sc.D., National Cancer Institute, Bethesda, Maryland

9:30 – 10:00 a.m.

Break (in Exhibit Hall)

10:00 - 11:00 a.m.

AMP Sponsored Session: Resident/Fellow Case Presentations

11:00 - 11:45 a.m.

Corporate Workshop*

12:00 - 1:00 p.m.

Lunch (in Exhibit Hall)

1:00 - 1:45 p.m.

Corporate Workshop*

2:00 - 2:45 p.m.

MALDI Imaging Mass Spectrometry: Technical Advances and Clinical Problem Solving
Jeremy L. Norris, Ph.D., Vanderbilt University, Nashville, Tennessee

2:45 - 3:30 p.m.

Molecular Testing in Lung Adenocarcinoma: Beyond EGFR and ALK
Maria E. Arcila, M.D., Memorial Sloan-Kettering Cancer Center, New York City, New York

3:30 - 4:00 p.m.

Break (in Exhibit Hall)

4:00 - 4:45 p.m.

Next Generation Sequencing and Precision Medicine in Hematolymphoid Malignancies
Sharathkumar Bhagavathi, M.D., University of Iowa Carver College of Medicine, Iowa City, Iowa

4:45 p.m.

Closing Remarks

*The corporate workshops are not endorsed by Beaumont Health System and are not part of the CME activity.

Thursday Program Moderators:
Bobby Boyanton, Jr., M.D., Medical Director, Microbiology, and Medical Director, Molecular Pathology, Beaumont Health, Royal Oak
Barbara Robinson-Dunn, Ph.D., D(ABMM), Technical Director, Microbiology, Beaumont Health, Royal Oak
Mark Micale, Ph.D., Director, Clinical Cytogenetics, Beaumont Health, Royal Oak
John Schwartz, M.D., Director, Immunopathology & Molecular Pathology, Anatomic Pathology, Beaumont Health, Royal Oak

“Go Green”
In accordance to be environmentally responsible, we are taking a “Go Green” approach to conference materials this year. No printed presentation materials will be provided. Handouts approved by speakers may be available for download one week prior to symposium. 

Maria E. Arcila, M.D., Memorial Sloan-Kettering Cancer Center, New York City, New York

Niaz Banaei, M.D., Stanford University, Stanford, California

Sharathkumar Bhagavathi, M.D., University of Iowa Carver College of Medicine, Iowa City, Iowa

Liang Cheng, M.D., Indiana University School of Medicine, Indianapolis

John P. Dekker, M.D., Ph.D., National Institute of Health, Bethesda, Maryland

David M. Engelthaler, Ph.D., Translational Genomics Research Institute, Flagstaff, Arizona

Dirk Hockemeyer, Ph.D., University of California, Berkeley, California 

Mitchell Machiela, Sc.D., National Cancer Institute, Bethesda, Maryland

Jeremy L. Norris, Ph.D., Vanderbilt University, Nashville, Tennessee

Antonia Sepulveda, M.D., Ph.D., Columbia University Medical Center, New York City, New York

Gregory J. Tsongalis, Ph.D., HCLD, CC, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine, Lebanon, New Hampshire

Clinical Pathology, department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, Michigan

Committee Members; OUWB School of Medicine Faculty

Barbara S. Ducatman, M.D., Chief, Pathology Service Line, Beaumont Health; Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

Mitual Amin, M.D.**, Chief, Anatomic Pathology; Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan 

Anne Marie Blenc, M.D., Associate Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

Bobby L. Boyanton, Jr., M.D., FASCP, FCAP**, Associate Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

Vonda Douglas-Nikitin, M.D., Associate Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

James Huang, M.D., Associate Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

Gabriel Maine, Ph.D.**, Associate Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

Mark Micale, Ph.D.**, FACMGG, Associate Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

Peter A. Millward, M.D., Associate Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

Vaishali Pansare, M.D., Associate Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

Barbara Robinson-Dunn, Ph.D., D(ABMM), Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

John Schwartz, M.D., Assistant Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

Marc D. Smith, M.D., Associate Professor, Oakland University William Beaumont School of Medicine, Rochester, Michigan

Mohamed Elbaz, M.S., MB(ASCP)CM, Supervisor, Advanced Diagnostics Lab, Anatomic Pathology, Beaumont Health, Royal Oak

John Gibson, M.S., SV(ASCP), CLSp(MB), CLAS-MDx, Corporate Supervisor, Microbiology and Molecular Pathology, Beaumont Health

Marcy King, B.S., Senior Executive Assistant, Symposium Coordinator, Pathology and Laboratory Medicine, Beaumont Health

Nancy Ramirez, M.S., MLS(ASCP)CM SHCM, Education Programs Manager; Program Director, School of Medical Laboratory Science

Alina Yaldo, B.S., Education Programs Secretary

Course Director**

Association for Molecular Pathology (AMP), Bethesda, Maryland

   Lucia P. Barker, Ph.D., Director, Education Programs

   Laurie Menser, Director of Strategic Development

   Mary Steele Williams, M.N.A., MT(ASCP)SM, C.A.E., Executive Director